Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Long-Term Investments (2016 - 2021)

Historic Long-Term Investments for Fortress Biotech (FBIO) over the last 8 years, with Q3 2021 value amounting to $56.9 million.

  • Fortress Biotech's Long-Term Investments rose 38502.94% to $56.9 million in Q3 2021 from the same period last year, while for Sep 2021 it was $56.9 million, marking a year-over-year increase of 38502.94%. This contributed to the annual value of $17.6 million for FY2020, which is 5757.09% up from last year.
  • Latest data reveals that Fortress Biotech reported Long-Term Investments of $56.9 million as of Q3 2021, which was up 38502.94% from $48.5 million recorded in Q2 2021.
  • Fortress Biotech's Long-Term Investments' 5-year high stood at $56.9 million during Q3 2021, with a 5-year trough of $1.2 million in Q1 2017.
  • In the last 5 years, Fortress Biotech's Long-Term Investments had a median value of $11.1 million in 2019 and averaged $13.7 million.
  • In the last 5 years, Fortress Biotech's Long-Term Investments plummeted by 4102.67% in 2017 and then surged by 38502.94% in 2021.
  • Over the past 5 years, Fortress Biotech's Long-Term Investments (Quarter) stood at $1.4 million in 2017, then skyrocketed by 380.22% to $6.7 million in 2018, then soared by 67.01% to $11.1 million in 2019, then surged by 57.57% to $17.6 million in 2020, then soared by 223.69% to $56.9 million in 2021.
  • Its Long-Term Investments stands at $56.9 million for Q3 2021, versus $48.5 million for Q2 2021 and $23.5 million for Q1 2021.